Concepedia

KJ Carroll

KC

Statistics

Publications

4

Citations

217

H-Index

4

Active since

1994

Affiliations

University of California, San Francisco(Current)

Oryn Therapeutics (United States)

Novartis (Switzerland)

Institute of Molecular Genetics

KJ Carroll is an author at University of California, San Francisco specializing in pharmacodynamic modeling, quantitative pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1994–2016

4

Publications

4

Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells

FC Zeigler, BD Bennett, SD Spencer et al. · Blood · 1994 · 140 citations · Full text

Batch‐to‐batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial

Elise Burmeister Getz, KJ Carroll, Byron Jones et al. · Clinical Pharmacology & Therapeutics · 2016 · 40 citations · Full text

, , +15

Between‐Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial

Elise Burmeister Getz, KJ Carroll, Johanna Mielke et al. · Clinical Pharmacology & Therapeutics · 2016 · 21 citations · Full text

Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells

FC Zeigler, BD Bennett, SD Spencer et al. · Blood · 1994 · 16 citations

1–4 of 4